P330: PROTEOMIC PROFILING UNCOVERS THERAPEUTIC VULNERABILITIES FOR TCF3 TRANSLOCATED B-CELL ACUTE LYMPHOBLASTIC LEUKEMIAS
Rebecca Hasselmann(Düsseldorf University Hospital), Ute Fischer(Dortmund University of Applied Sciences and Arts), Beat Bornhäuser(University Children's Hospital Zurich), Martin Stanulla(Leibniz University Hannover), Lena Blümel(German Cancer Research Center), Blerim Marovca(University Children's Hospital Zurich), Arndt Borkhardt(Düsseldorf University Hospital), Nan Qin(China Pharmaceutical University), Vera H. Jepsen(Heinrich Heine University Düsseldorf), Jasmin Bartl(Universität Hamburg), Sanil Bhatia(University Medical Center), Marc Remke(Saarland University), Jean‐Pierre Bourquin(University Children's Hospital Zurich), Florent Dingli(Institut Curie), Véronique Marsaud(Université Paris-Sud), Daniel Picard(Heidelberg University), Flavia Bernardi(Université Paris-Sud), Olivier Ayrault(St. Jude Children's Research Hospital), Jacob Torrejon-Diaz(Centre National de la Recherche Scientifique), Damarys Loew(Institut Curie)
Cited by 0
Related Papers
Insertional oncogenesis in 4 patients after retrovirus-mediated gene therapy of SCID-X1
|Journal of Clinical Investigation|2008|1.8k
Intertumoral Heterogeneity within Medulloblastoma Subgroups
|Cancer Cell|2017|1.3k